Empagliflozin & Metformin Hydrochloride Tablets (EMPAGILM 12.5/500)
Empagliflozin & Metformin Hydrochloride Tablets (EMPAGILM 12.5/500)
Product Name: EMPAGILM 12.5/500
Composition: Each tablet contains:
- Empagliflozin 12.5 mg
- Metformin Hydrochloride 500 mg
Product Overview
EMPAGILM 12.5/500 is a powerful combination of Empagliflozin and Metformin Hydrochloride designed to effectively manage Type 2 Diabetes Mellitus. This dual-action formula helps improve glycemic control by targeting multiple pathways involved in blood sugar regulation.
How It Works
? Empagliflozin (SGLT2 inhibitor) – Works by reducing glucose reabsorption in the kidneys, increasing urinary glucose excretion, and lowering blood sugar levels.
? Metformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, improves insulin sensitivity, and increases glucose uptake by muscles.
Indications
EMPAGILM 12.5/500 is indicated for:
- Management of Type 2 Diabetes Mellitus in adults
- Patients inadequately controlled on Metformin or Empagliflozin alone
- As an adjunct to diet and exercise to improve glycemic control
Benefits
?? Effective reduction in fasting and postprandial blood sugar levels
?? Promotes weight loss and reduces the risk of cardiovascular complications
?? Enhances overall insulin sensitivity and beta-cell function
?? Lowers the risk of hypoglycemia due to its balanced action
Dosage & Administration
- Recommended Dose: One tablet daily, with meals or as directed by a healthcare professional.
- Adjustments may be required based on individual patient response and tolerance.
Precautions
- Not recommended for patients with severe renal impairment
- Monitor for signs of lactic acidosis (due to Metformin) and dehydration (due to Empagliflozin)
- Caution in patients with a history of urinary tract infections
Storage
- Store in a cool, dry place below 30°C
- Keep out of reach of children
Why Choose EMPAGILM 12.5/500?
???? Combines the complementary effects of two proven anti-diabetic agents
???? Enhances glycemic control while supporting cardiovascular health
???? Convenient once-daily dosing for improved patient compliance
Empagilm 12.5/500 – Empowering Diabetes Management with Precision and Care.